Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
10-13 September, 2025
Not Confirmed
Not Confirmed
12-16 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
10-13 September, 2025
Industry Trade Show
Not Confirmed
12-16 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
29 Aug 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-08-29/beone-medicines-announces-positive-topline-results-for-sonrotoclax-in-relapsed-or-refractory-mantle
27 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250827132948/en/European-Commission-Approves-TEVIMBRA-as-NeoadjuvantAdjuvant-NSCLC-Treatment-Ahead-of-Late-Breaking-Data-Presentation-at-WCLC-2025
26 Aug 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/beone-bags-885m-royalty-deal-amgen-lung-cancer-drug-imdelltra
21 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250821182068/en/European-Commission-Approves-Tablet-Formulation-of-BeOne-Medicines-BRUKINSA-for-All-Approved-Indications
06 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250806769630/en/BeOne-Medicines-Announces-Second-Quarter-2025-Financial-Results-and-Business-Updates
31 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250731014937/en/BeOne-Medicines-Receives-PRIME-Designation-from-the-European-Medicines-Agency-for-BGB-16673-in-Waldenstroms-Macroglobulinemia
ABOUT THIS PAGE